{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:39:39Z","timestamp":1790746779000,"version":"4.1.0"},"reference-count":70,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Fas-associated phosphatase 1 (FAP-1), a nonreceptor protein tyrosine phosphatase, has been implicated in multiple signaling pathways, but its in vivo role remains unclear. In this study, we showed that FAP-1\u2013deficient (FAP-1\u0394P\/\u0394P) mice develop early megakaryocyte (MK) hyperplasia with defective platelet function and occasional hemorrhagic manifestations, accompanied by myelofibrosis (MF)-like features, in aged animals. Bone marrow analyses revealed impaired demarcation membrane system (DMS) development with pre-DMS arrest in MK, which led to defective proplatelet formation, impaired platelet function, and prolonged bleeding that was partly associated with reduced clot retraction. Mechanistically, a FAP-1 deficiency induces sustained Src activation and cofilin inactivation, thereby impairing the perinuclear actin remodeling required for DMS expansion and leading to pre-DMS arrest. With aging, approximately half of the mice developed a symptomatic phenotype, characterized by extramedullary hematopoiesis, hepatosplenomegaly, anemia, and thrombocytopenia; among these, most remained in a prefibrotic state, whereas a subset progressed to fibrosis-like changes. A bone marrow transplantation demonstrated that the MK abnormalities and fibrosis-associated changes were hematopoietic cell\u2013intrinsic and partially transferable. Pharmacologic inhibition of Src with dasatinib attenuated these defects in FAP-1\u2013deficient mice, supporting pathway specificity. In patients with primary MF, reduced FAP-1 expression is associated with pre-DMS MK accumulation, abnormal DMS and actin organization, and Src activation, thus supporting clinical relevance. Collectively, we identified a FAP-1\u2013dependent mechanism that governs the Src-cofilin\u2013mediated actin remodeling required for MK maturation and platelet function and suggest this pathway as a potential therapeutic target for platelet dysfunction, hemorrhagic complications, and fibrosis-associated disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031490","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:03:36Z","timestamp":1781543016000},"page":"1440-1453","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["FAP-1 loss impairs megakaryocyte demarcation membrane system and platelet function with myelofibrosis-like features"],"prefix":"10.1182","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9211-5589","authenticated-orcid":false,"given":"Mu-Fan","family":"Chiu","sequence":"first","affiliation":[{"name":"1Department and Graduate Institute of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7306-174X","authenticated-orcid":false,"given":"Kun-Huei","family":"Yeh","sequence":"additional","affiliation":[{"name":"2Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan"},{"name":"3Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8316-3785","authenticated-orcid":false,"given":"Pei-Jer","family":"Chen","sequence":"additional","affiliation":[{"name":"4Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan"},{"name":"5Center of Precision Medicine, National Taiwan University, Taipei, Taiwan"},{"name":"6Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2967-698X","authenticated-orcid":false,"given":"Wen-Chien","family":"Chou","sequence":"additional","affiliation":[{"name":"7Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"8Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5042-0503","authenticated-orcid":false,"given":"Chung-Wu","family":"Lin","sequence":"additional","affiliation":[{"name":"9Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan"},{"name":"10Department of Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko-Ping","family":"Chang","sequence":"additional","affiliation":[{"name":"9Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7160-2285","authenticated-orcid":false,"given":"Chien-Chin","family":"Lin","sequence":"additional","affiliation":[{"name":"8Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4509-180X","authenticated-orcid":false,"given":"Shiou-Hwei","family":"Yeh","sequence":"additional","affiliation":[{"name":"1Department and Graduate Institute of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan"},{"name":"5Center of Precision Medicine, National Taiwan University, Taipei, Taiwan"},{"name":"11Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"12","key":"2026091007220176100_bib1","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3390\/biom10121659","article-title":"Dual role of the PTPN13 tyrosine phosphatase in cancer","volume":"10","author":"McHeik","year":"2020","journal-title":"Biomolecules"},{"issue":"4","key":"2026091007220176100_bib2","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1158\/1078-0432.CCR-05-1383","article-title":"Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma","volume":"12","author":"Yeh","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"18","key":"2026091007220176100_bib3","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1074\/jbc.M112.429696","article-title":"Fas-associated phosphatase 1 (Fap1) influences betacatenin activity in myeloid progenitor cells expressing the Bcr-abl oncogene","volume":"288","author":"Huang","year":"2013","journal-title":"J Biol Chem"},{"issue":"1","key":"2026091007220176100_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1152\/physiolgenomics.00079.2004","article-title":"Mild impairment of motor nerve repair in mice lacking PTP-BL tyrosine phosphatase activity","volume":"19","author":"Wansink","year":"2004","journal-title":"Physiol Genomics"},{"issue":"9","key":"2026091007220176100_bib5","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1111\/j.1460-9568.2005.04065.x","article-title":"Effects of LAR and PTP-BL phosphatase deficiency on adult mouse retinal cells activated by lens injury","volume":"21","author":"Lorber","year":"2005","journal-title":"Eur J Neurosci"},{"issue":"2","key":"2026091007220176100_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.immuni.2007.01.010","article-title":"Regulation of signal transducer and activator of transcription signaling by the tyrosine phosphatase PTP-BL","volume":"26","author":"Nakahira","year":"2007","journal-title":"Immunity"},{"issue":"2","key":"2026091007220176100_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1158\/1078-0432.CCR-12-2087","article-title":"The role of JAK pathway dysregulation in the pathogenesis and treatment of acute myeloid leukemia","volume":"19","author":"Lee","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"22","key":"2026091007220176100_bib8","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1056\/NEJMra1406186","article-title":"Myeloproliferative Neoplasms","volume":"376","author":"Spivak","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"2026091007220176100_bib9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","article-title":"Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms","volume":"129","author":"Vainchenker","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2026091007220176100_bib10","first-page":"76","article-title":"A review of essential thrombocythemia and its complications","volume":"21","author":"Babakhanlou","year":"2023","journal-title":"Clin Adv Hematol Oncol"},{"issue":"21","key":"2026091007220176100_bib11","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1182\/blood-2010-07-293761","article-title":"Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification","volume":"117","author":"Thiele","year":"2011","journal-title":"Blood"},{"key":"2026091007220176100_bib12","doi-asserted-by":"crossref","first-page":"e21015","DOI":"10.1371\/journal.pone.0021015","article-title":"In vitro megakaryocyte differentiation and proplatelet formation in Ph-negative classical myeloproliferative neoplasms: distinct patterns in the different clinical phenotypes","volume":"6","author":"Balduini","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"2026091007220176100_bib13","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00277-017-3099-2","article-title":"The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review","volume":"96","author":"Kc","year":"2017","journal-title":"Ann Hematol"},{"issue":"1","key":"2026091007220176100_bib14","doi-asserted-by":"crossref","first-page":"e2018068","DOI":"10.4084\/mjhid.2018.068","article-title":"Megakaryocyte contribution to bone marrow fibrosis: many arrows in the quiver","volume":"10","author":"Malara","year":"2018","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"9","key":"2026091007220176100_bib15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ajh.24788","article-title":"Pre-fibrotic\/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: the impact of minor clinical diagnostic criteria on the outcome of the disease","volume":"92","author":"Jeryczynski","year":"2017","journal-title":"Am J Hematol"},{"issue":"10","key":"2026091007220176100_bib16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41408-020-00368-1","article-title":"A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis","volume":"10","author":"Carobbio","year":"2020","journal-title":"Blood Cancer J"},{"issue":"22","key":"2026091007220176100_bib17","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood.V128.22.943.943","article-title":"Differences in clinical and molecular characteristics and outcome in prefibrotic and overt primary myelofibrosis according to 2016 WHO criteria. a study on 639 patients of the Agimm Group","volume":"128","author":"Guglielmelli","year":"2016","journal-title":"Blood"},{"issue":"24","key":"2026091007220176100_bib18","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.3390\/jcm10245831","article-title":"Extramedullary hematopoiesis of the liver and spleen","volume":"10","author":"Cenariu","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"2026091007220176100_bib19","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3324\/haematol.2024.285598","article-title":"Different inflammatory, fibrotic, and immunological signatures between pre-fibrotic and overt primary myelofibrosis","volume":"110","author":"Jung","year":"2025","journal-title":"Haematologica"},{"issue":"5","key":"2026091007220176100_bib20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ajh.26857","article-title":"Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am J Hematol"},{"issue":"7","key":"2026091007220176100_bib21","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3324\/haematol.2024.287236","article-title":"New insights into the generation and function of megakaryocytes in health and disease","volume":"110","author":"Du","year":"2025","journal-title":"Haematologica"},{"issue":"6","key":"2026091007220176100_bib22","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/bjh.12328","article-title":"Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside","volume":"161","author":"Deutsch","year":"2013","journal-title":"Br J Haematol"},{"issue":"3","key":"2026091007220176100_bib23","doi-asserted-by":"crossref","first-page":"030503","DOI":"10.11613\/BM.2024.030503","article-title":"A modern overview of the process of platelet formation (thrombocytopoiesis) and its dependence on several factors","volume":"34","author":"Ivanovna Gabrilchak","year":"2024","journal-title":"Biochem Med (Zagreb)"},{"key":"2026091007220176100_bib24","doi-asserted-by":"crossref","first-page":"584541","DOI":"10.3389\/fonc.2020.584541","article-title":"Shared and distinctive ultrastructural abnormalities expressed by megakaryocytes in bone marrow and spleen from patients with myelofibrosis","volume":"10","author":"Zingariello","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"2026091007220176100_bib25","first-page":"126","article-title":"Static and functional morphology of the pathological platelets in primary myelofibrosis and myeloproliferative syndrome","volume":"8","author":"Hattori","year":"1975","journal-title":"Ser Haematol"},{"issue":"2","key":"2026091007220176100_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.hoc.2020.11.004","article-title":"The role of megakaryocytes in myelofibrosis","volume":"35","author":"Melo-Cardenas","year":"2021","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"2026091007220176100_bib27","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/jha2.983","article-title":"IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8\/a9 and NFkappaB signaling in vivo","volume":"5","author":"Lin","year":"2024","journal-title":"EJHaem"},{"issue":"1","key":"2026091007220176100_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yexcr.2011.10.003","article-title":"Hirudin and heparin enable efficient megakaryocyte differentiation of mouse bone marrow progenitors","volume":"318","author":"Strassel","year":"2012","journal-title":"Exp Cell Res"},{"issue":"2","key":"2026091007220176100_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5493\/wjem.v2.i2.30","article-title":"Standardizing a simpler, more sensitive and accurate tail bleeding assay in mice","volume":"2","author":"Liu","year":"2012","journal-title":"World J Exp Med"},{"issue":"4","key":"2026091007220176100_bib30","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2002-06-1913","article-title":"Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice)","volume":"100","author":"Vannucchi","year":"2002","journal-title":"Blood"},{"issue":"10","key":"2026091007220176100_bib31","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S1357-2725(99)00079-5","article-title":"Thrombopoietin and the c-Mpl receptor: insights from gene targeting","volume":"31","author":"Alexander","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"2026091007220176100_bib32","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/liv.13317","article-title":"Thrombocytopenia in chronic liver disease","volume":"37","author":"Peck-Radosavljevic","year":"2017","journal-title":"Liver Int"},{"key":"2026091007220176100_bib33","first-page":"5","article-title":"Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-beta","volume":"3","author":"Agarwal","year":"2016","journal-title":"Stem Cell Investig"},{"issue":"6","key":"2026091007220176100_bib34","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood-2013-03-492330","article-title":"Biogenesis of the demarcation membrane system (DMS) in megakaryocytes","volume":"123","author":"Eckly","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2026091007220176100_bib35","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/jth.13318","article-title":"Cdc42-dependent F-actin dynamics drive structuration of the demarcation membrane system in megakaryocytes","volume":"14","author":"Antkowiak","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2026091007220176100_bib36","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/jth.14544","article-title":"New insights into cytoskeletal remodeling during platelet production","volume":"17","author":"Ghalloussi","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"13","key":"2026091007220176100_bib37","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cub.2013.05.005","article-title":"Actin filament severing by cofilin dismantles actin patches and produces mother filaments for new patches","volume":"23","author":"Chen","year":"2013","journal-title":"Curr Biol"},{"issue":"2-3","key":"2026091007220176100_bib38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-4889(03)00087-9","article-title":"Actin remodeling to facilitate membrane fusion","volume":"1641","author":"Eitzen","year":"2003","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"2026091007220176100_bib39","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1172\/JCI114538","article-title":"Regulation of megakaryocyte phenotype in human erythroleukemia cells","volume":"85","author":"Long","year":"1990","journal-title":"J Clin Invest"},{"key":"2026091007220176100_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-1-60761-376-3_4","article-title":"Jasplakinolide: an actin-specific reagent that promotes actin polymerization","volume":"586","author":"Holzinger","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"49","key":"2026091007220176100_bib41","doi-asserted-by":"crossref","first-page":"49293","DOI":"10.1074\/jbc.M307021200","article-title":"Epidermal growth factor-dependent regulation of Cdc42 is mediated by the Src tyrosine kinase","volume":"278","author":"Tu","year":"2003","journal-title":"J Biol Chem"},{"issue":"7","key":"2026091007220176100_bib42","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nrm1159","article-title":"Another two stings in WASP's tail","volume":"4","author":"Bussell","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"2026091007220176100_bib43","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1074\/jbc.R110.200329","article-title":"Signaling role of Cdc42 in regulating mammalian physiology","volume":"286","author":"Melendez","year":"2011","journal-title":"J Biol Chem"},{"issue":"13","key":"2026091007220176100_bib44","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.cub.2017.05.048","article-title":"ADF\/Cofilin accelerates actin dynamics by severing filaments and promoting their depolymerization at both ends","volume":"27","author":"Wioland","year":"2017","journal-title":"Curr Biol"},{"issue":"10","key":"2026091007220176100_bib45","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1182\/blood-2010-03-274340","article-title":"ADF\/n-cofilin-dependent actin turnover determines platelet formation and sizing","volume":"116","author":"Bender","year":"2010","journal-title":"Blood"},{"issue":"21","key":"2026091007220176100_bib46","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1111\/1759-7714.14657","article-title":"Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src\/ERK\/YAP1 signaling","volume":"13","author":"Wang","year":"2022","journal-title":"Thorac Cancer"},{"issue":"6","key":"2026091007220176100_bib47","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ctrv.2010.02.015","article-title":"Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors","volume":"36","author":"Araujo","year":"2010","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"2026091007220176100_bib48","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1016\/j.bbamcr.2014.08.014","article-title":"PTPN13 regulates cellular signalling and \u03b2-catenin function during megakaryocytic differentiation","volume":"1843","author":"Sardina","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"2026091007220176100_bib49","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/s41375-022-01610-4","article-title":"Germline PTPN13 mutations in patients with bone marrow failure and acute lymphoblastic leukemia","volume":"36","author":"Moshiri","year":"2022","journal-title":"Leukemia"},{"issue":"29","key":"2026091007220176100_bib50","doi-asserted-by":"crossref","first-page":"11933","DOI":"10.1073\/pnas.0701077104","article-title":"Src phosphorylation of cortactin enhances actin assembly","volume":"104","author":"Tehrani","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2026091007220176100_bib51","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/onc.2009.319","article-title":"Tyrosine phosphorylation of cofilin at Y68 by v-Src leads to its degradation through ubiquitin-proteasome pathway","volume":"29","author":"Yoo","year":"2010","journal-title":"Oncogene"},{"issue":"7","key":"2026091007220176100_bib52","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1182\/blood-2006-10-055087","article-title":"Mutations in the cofilin partner Aip1\/Wdr1 cause autoinflammatory disease and macrothrombocytopenia","volume":"110","author":"Kile","year":"2007","journal-title":"Blood"},{"issue":"4","key":"2026091007220176100_bib53","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/leu.2011.258","article-title":"Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria","volume":"26","author":"Finazzi","year":"2012","journal-title":"Leukemia"},{"issue":"5","key":"2026091007220176100_bib54","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/bjh.19337","article-title":"Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera-A matched nationwide population-based study","volume":"204","author":"Enblom-Larsson","year":"2024","journal-title":"Br J Haematol"},{"issue":"3","key":"2026091007220176100_bib55","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3324\/haematol.12053","article-title":"Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments","volume":"93","author":"De Stefano","year":"2008","journal-title":"Haematologica"},{"issue":"6","key":"2026091007220176100_bib56","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1055\/s-2006-949664","article-title":"The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera","volume":"32","author":"Michiels","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"16","key":"2026091007220176100_bib57","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1073\/pnas.1404354111","article-title":"Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation","volume":"111","author":"Ng","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2026091007220176100_bib58","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/ajh.23562","article-title":"Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists","volume":"88","author":"Makar","year":"2013","journal-title":"Am J Hematol"},{"issue":"19","key":"2026091007220176100_bib59","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1158\/1078-0432.CCR-18-4089","article-title":"Activation of JAK\/STAT signaling in megakaryocytes sustains myeloproliferation in vivo","volume":"25","author":"Woods","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2026091007220176100_bib60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/modpathol.2016.182","article-title":"The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations","volume":"30","author":"Gianelli","year":"2017","journal-title":"Mod Pathol"},{"issue":"1","key":"2026091007220176100_bib61","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/s12967-023-04393-z","article-title":"Fibrosis and bone marrow: understanding causation and pathobiology","volume":"21","author":"Ghosh","year":"2023","journal-title":"J Transl Med"},{"issue":"328","key":"2026091007220176100_bib62","doi-asserted-by":"crossref","first-page":"328ra30","DOI":"10.1126\/scitranslmed.aad7666","article-title":"A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies","volume":"8","author":"Turro","year":"2016","journal-title":"Sci Transl Med"},{"issue":"3","key":"2026091007220176100_bib63","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3324\/haematol.2020.268516","article-title":"Pathogenetic and clinical study of a patient with thrombocytopenia due to the p.E527K gain-of-function variant of SRC","volume":"106","author":"Barozzi","year":"2021","journal-title":"Haematologica"},{"issue":"18","key":"2026091007220176100_bib64","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood.2019002848","article-title":"Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice","volume":"135","author":"Nagy","year":"2020","journal-title":"Blood"},{"issue":"4","key":"2026091007220176100_bib65","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jha2.954","article-title":"Treatment comparison of hydroxyurea versus ruxolitinib in essential thrombocythaemia: a matched-cohort analysis","volume":"5","author":"Grunwald","year":"2024","journal-title":"EJHaem"},{"issue":"7","key":"2026091007220176100_bib66","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00277-024-05665-4","article-title":"ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options","volume":"103","author":"Kiladjian","year":"2024","journal-title":"Ann Hematol"},{"issue":"12","key":"2026091007220176100_bib67","doi-asserted-by":"crossref","first-page":"e202309021","DOI":"10.1083\/jcb.202309021","article-title":"Mechanisms of actin disassembly and turnover","volume":"222","author":"Goode","year":"2023","journal-title":"J Cell Biol"},{"key":"2026091007220176100_bib68","doi-asserted-by":"crossref","first-page":"a001800","DOI":"10.1101\/cshperspect.a001800","article-title":"The growth cone cytoskeleton in axon outgrowth and guidance","volume":"3","author":"Dent","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"14","key":"2026091007220176100_bib69","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1523\/JNEUROSCI.21-14-05169.2001","article-title":"Stages of synapse development defined by dependence on F-actin","volume":"21","author":"Zhang","year":"2001","journal-title":"J Neurosci"},{"issue":"5","key":"2026091007220176100_bib70","doi-asserted-by":"crossref","first-page":"jcs259969","DOI":"10.1242\/jcs.259969","article-title":"Actin turnover protects the cytokinetic contractile ring from structural instability","volume":"136","author":"McDargh","year":"2023","journal-title":"J Cell Sci"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/11\/1440\/2588115\/blood_bld-2025-031490-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/11\/1440\/2588115\/blood_bld-2025-031490-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:22:28Z","timestamp":1789039348000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/11\/1440\/569132\/FAP-1-loss-impairs-megakaryocyte-demarcation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,9,10]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031490","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,10]]},"published":{"date-parts":[[2026,9,10]]}}}